Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A TV screen graphs the day's activity at the New York Stock Exchange, Aug. 5. Photo: Johannes Eisele/AFP/Getty Images

Stocks continued their sell-off overnight as fears of further escalation in the U.S.-China trade war were realized after markets closed on Monday.

The big picture: Investors are beginning to fear that not only will the trade war dent business confidence and economic growth, but with further escalation and no end in sight, it could do massive damage to the entire global economy.

What they're saying: "These types of beggar-thy-neighbor policies were a hallmark of the Great Depression and caused a much larger economic downturn in its aftermath," said Joe Brusuelas, chief economist at consulting firm RSM.

  • Jim Paulsen, chief investment strategist at The Leuthold Group, wrote in a note to clients: "If the stimulus introduced about the globe in the last six to nine months does not trigger at least some bounce in the economic and earnings recovery, it won’t be recession fears that will spike, it will be depression fears."

Driving the news: The U.S. Treasury Department officially declared China a currency manipulator Monday night. It's a meaningless designation that the Trump administration has passed on before and is now making without any real evidence. In response, the Chinese Ministry of Commerce confirmed Chinese companies have stopped purchasing U.S. agricultural products.

By the numbers: Stocks have continued to fall around the world.

  • Asian stocks fell further overnight, with China's Shanghai Composite Index down 1.6%, Japan's Nikkei 0.6% lower, Australian stocks down 2.4% and South Korea's KOSPI off by 1.5%.
  • That followed losses of 3% on the S&P 500 with the Nasdaq dropping 3.5% and the Dow closing 767 points, or 2.9%, lower on Monday, the worst day for the U.S. stock market of 2019.

Of note: Other markets, including bonds, currencies and commodities, have had more subdued reactions, as investors in those assets had priced in more downside risk already.

  • The U.S. Treasury yield curve, which first inverted in March, moved further negative, with 3-month T-bills holding yields 32 basis points higher than 10-year notes.

Be smart: “The fundamentals are impacted by the trade war and by tariffs, but that’s not the only reason for the sell-off," Peter Cecchini, global chief market strategist at Cantor Fitzgerald, told Bloomberg.

  • "I think it’s a deeper wound in the global economy that the market is suffering right now."

Editor's note: This piece was clarified to describe RSM as a consulting firm (rather than asset manager).

Go deeper

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities in Syria linked to Iranian-backed militia groups was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

6 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios